News & views

Series A funding and exclusive UCL licence will take forward potential therapeutic for motor neurone disease.

Oriole - who are using light to train LLMs with a fraction of the usual AI energy consumption – will further scale its “super-brain” solution.

The first-ever patient with the rare immunodeficiency CGD has been successfully treated at Great Ormond Street.

This I-O Converse session saw Dr. Maria Leiloglou, CEO and Co-founder of Enacuity, discuss her journey and challenges to date.

The findings from Queen Square Analytics uncovers two distinct types of multiple scelrosis.

Scaling AI to transform some of the world’s most energy-intensive industries, Gigaton will accelerate its next stage of growth.

After a dramatic COP30 in Brazil, we take a look at two spinouts supporting the transition – Oriole Networks and Gigaton.

Professor Toby Cubitt is the CTO and co-founder of Phasecraft, a quantum algorithms spinout designing quantum algorithms that can work on today’s hardware.

CAR T harnesses the power of a patient’s immune system to combat their cancer.

With just three minutes and four slides each, participants pitched their ideas to an audience of venture capitalists, academics, and innovation professionals.

His move comes after 24 years working at UCL and since August 2006, at UCL Ventures.

Our spinouts have taken centre stage in MedCity's ‘London Life Sciences Companies to Watch’ report.